Ann Low is a co-founder of Cancer Fund, a Phoenix-based venture capital firm that invests exclusively in early-stage cancer innovations. See contact routes.
Ann Low is a co-founder of Cancer Fund, a Phoenix-based venture capital firm that invests exclusively in early-stage cancer innovations, targeting Seed and Series A rounds in sectors including therapies, diagnostics, and prevention. The firm’s distinctive thesis focuses on translating decades of cancer research into accessible treatments to improve patient outcomes and reduce costs, with its first investment being Reglagene, a company developing noninvasive gene-reprogramming therapies. While specific check sizes are not publicly disclosed, Cancer Fund I aims to invest in 30–40 companies across healthcare and life science sectors focused on oncology.
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Phoenix.
Investors like Ann Low · Full investor directory · Investor access · Company funding database